Takeda hire indicates broad change

Share this article:

Takeda's new president is getting attention. The company announced last week that it named former GSK-er Chris Weber CEO. The New York Times noted in its coverage that appointing a French citizen is in line with a trend among Japanese companies to look abroad for hires, and Bloomberg noted Wednesday that Weber not only lacks Takeda experience, but is also the first non-Japanese executive to lead the company.

Weber is expected to be named CEO in April, when Yasuchika Hasegawa leaves. Robert Dujarric of the Institute of Contemporary Asian Studies at Temple University told Bloomberg that the unique hire has a benefit beyond just being different. “A guy who's not from Takeda, whether he's Japanese or foreign, can much more easily fire people, restructure and close businesses,” he said.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.